Rocket


News + Filings
Transactions



Dier Mardi

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/09/2023ACELYRIN, Inc. Other (acquisition)Employee Stock Option (right to buy)673.6k$5.88$4M 05/09/2023
05/09/2023ACELYRIN, Inc. Other (disposition)Employee Stock Option (right to buy)673.6k$5.88$4M 05/09/2023
05/09/2023ACELYRIN, Inc. PurchaseCommon Stock875$18.00$15.8kSee footnote05/09/2023
05/09/2023ACELYRIN, Inc. PurchaseCommon Stock875$18.00$15.8kSee footnote05/09/2023
05/09/2023ACELYRIN, Inc. PurchaseCommon Stock5.6k$18.00$100k 05/09/2023
05/09/2023ACELYRIN, Inc. Other (acquisition)Employee Stock Option (right to buy)85.2k$18.00$1.5M 05/09/2023
05/09/2023ACELYRIN, Inc. Other (disposition)Employee Stock Option (right to buy)85.2k$18.00$1.5M 05/09/2023
05/04/2023ACELYRIN, Inc. GrantEmployee Stock Option (right to buy)85.2k$18.00$1.5M 05/04/2023
10/14/2022Ultragenyx Pharmaceutical Inc.RARESaleCommon Stock1.6k$40.16$65.4k 10/14/2022
10/12/2022Ultragenyx Pharmaceutical Inc.RARESaleCommon Stock3.5k$38.22$133.2k 10/12/2022
09/16/2022Ultragenyx Pharmaceutical Inc.RAREGrantCommon Stock20k$0.00$0 09/16/2022
06/17/2022Prelude Therapeutics IncPRLDGrantDirector Stock Option (Right to Buy)34.3k$4.74$162.6k 06/17/2022
06/17/2022Oric Pharmaceuticals, Inc.ORICGrantStock Option (right to buy)53.7k$3.75$201.4k 06/17/2022
03/03/2022Ultragenyx Pharmaceutical Inc.RARESaleCommon Stock420$64.55$27.1k 03/01/2022
03/01/2022Ultragenyx Pharmaceutical Inc.RAREGrantStock Option (Right to Buy)24.9k$67.37$1.7M 03/01/2022
03/01/2022Ultragenyx Pharmaceutical Inc.RARESaleCommon Stock534$66.62$35.6k 03/01/2022
03/01/2022Ultragenyx Pharmaceutical Inc.RAREGrantCommon Stock14k$0.00$0 03/01/2022
10/14/2021Ultragenyx Pharmaceutical Inc.RARESaleCommon Stock3.3k$81.16$264.7k 10/12/2021
10/12/2021Ultragenyx Pharmaceutical Inc.RARESaleCommon Stock3.5k$82.79$287.9k 10/12/2021
06/18/2021Prelude Therapeutics IncPRLDGrantDirector Stock Option (Right to Buy)23.3k$31.02$724.1k 06/18/2021
06/16/2021Oric Pharmaceuticals, Inc.ORICGrantStock Option (right to buy)16.6k$19.03$316.4k 06/16/2021
06/02/2021Adamas Pharmaceuticals IncADMSGrantCommon Stock5k$0.00$0 06/02/2021
06/02/2021Adamas Pharmaceuticals IncADMSGrantStock Option (Right to Buy)10k$5.21$52.1k 06/02/2021
03/01/2021Ultragenyx Pharmaceutical Inc.RAREGrantCommon Stock5.5k$0.00$0 03/01/2021
03/01/2021Ultragenyx Pharmaceutical Inc.RAREGrantStock Option (Right to Buy)11k$142.47$1.6M 03/01/2021
10/12/2020Ultragenyx Pharmaceutical Inc.RAREGrantCommon Stock40k$0.00$0 10/12/2020
10/12/2020Ultragenyx Pharmaceutical Inc.RAREGrantStock Option (Right to Buy)40k$95.50$3.8M 10/12/2020
09/29/2020Prelude Therapeutics IncPRLDPurchaseCommon Stock10k$19.00$190k 09/29/2020
09/24/2020Prelude Therapeutics IncPRLDGrantDirector Stock Option (right to buy)3.5k$19.00$65.7k 09/24/2020
07/02/2020PORTOLA PHARMACEUTICALS INCPTLADispositionCommon Stock39.6k$18.00$712.1k 07/02/2020
07/02/2020PORTOLA PHARMACEUTICALS INCPTLADispositionCommon Stock10$18.00$180 07/02/2020
07/02/2020PORTOLA PHARMACEUTICALS INCPTLADispositionPerformance Stock Units48.8k$0.00$0 07/02/2020
07/02/2020PORTOLA PHARMACEUTICALS INCPTLADispositionPerformance Stock Units24.4k$0.00$0 07/02/2020
07/02/2020PORTOLA PHARMACEUTICALS INCPTLADispositionStock Option (Right to Buy)65k$12.79$831.4k 07/02/2020
07/02/2020PORTOLA PHARMACEUTICALS INCPTLADispositionStock Option (Right to Buy)32.5k$12.79$415.7k 07/02/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy